(Q53604027)

16 May 2018

title

Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract. (English)

1 reference

16 May 2018

0 references

1 reference

Seok Jin Kim

1

1 reference

16 May 2018

Byung Soo Kim

2

1 reference

16 May 2018

Chul Won Choi

3

1 reference

16 May 2018

Hee Yun Seo

4

1 reference

16 May 2018

Hye Ryoung Seol

5

1 reference

16 May 2018

Hwa Jung Sung

6

1 reference

16 May 2018

In Sun Kim

7

1 reference

16 May 2018

Chul Yong Kim

8

1 reference

16 May 2018

Kwang Yoon Jung

9

1 reference

16 May 2018

Jun Suk Kim

10

1 reference

16 May 2018

publication date

1 July 2006

1 reference

16 May 2018

published in

Leukemia & Lymphoma

1 reference

16 May 2018

volume

47

1 reference

16 May 2018

issue

7

1 reference

16 May 2018

page(s)

1265-1273

1 reference

16 May 2018

Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Nasal and nasal-type natural killer/T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Nasal-type NK/T cell lymphoma: clinical features and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190600565651

10.1080/10428190600565651

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

16923556

1 reference

16 May 2018